Empty Capsules Market

Industry Insights-

• The Global Empty Capsules Market was valued at USD 2256.9 Million in 2020
• It is anticipated to reach USD 3707.8 Million by 2027
• A CAGR of 7.35% is anticipated over the forecast period

Market Overview-

Empty Capsules are comprised of gelatin (hard or delicate) and non-gelatin shells commonly got from hydrolysis of collagen such as alkaline, acid, thermal hydrolysis or enzymatic from animal origin or cellulose based. Empty capsules can be stored in different forms such as powder, herbs or medicine on a specific dosage form. These capsules are very popular because of their high absorption rate. The empty capsules are available in different flavors with different colors.

The capsules are the most favored strong measurements structures due to their various benefits such as better satisfactoriness and a quicker absorption rate, which represents the greatest demand of these empty capsules in the drug business for the therapy of a number of chronic and irresistible infections. The empty capsules are mostly a packaging structure simple to acknowledge, with a cheap material, from where its achievement in medical clinic, in drug stores, and even at private people doing themselves their combinations of plants.

Covid-19 Impact-

Covid-19 pandemic, has witnessed a positive impact on the growth of the empty capsule market globally  owing to the increasing demand for use of vitamins supplements from people across the world for boosting up immunity. During Covid-19 pandemic, vitamins and other herbal medicines are taking a center platform hence demand of empty capsules is increasing rapidly. Empty capsules are valuable in veiling the flavor of cardiovascular treatment drugs. This factor will positively affect the empty capsule market. Hence, the growth of the empty capsule market on post-pandemic will increase.

Key Players-

Some of the key players for global Empty Capsules Market are

• ACG Worldwide
• CapsCanada Corporation
• Bright Pharma Caps Inc.
• Sunil Healthcare Ltd.
• Medi-Caps Ltd.
• Mitsubishi Chemical Holdings Corporation (Qualicaps Inc.)
• Roxlor LLC
• Snail Pharma Industry Co. Ltd
• Suheung Co. Ltd
• Qingdao Yiqing Medicinal Capsules Co. Ltd.
• Lonza Group AG
• HealthCaps India Ltd.
• others

Segmentation Analysis-

By Product:

• Gelatin Capsule
• Soft Gelatin Capsule (SGC)
• Hard Gelatin Capsule (HGC)
• Non-Gelatin Capsule

Based on Product, the global empty capsules market is segmented as gelatin capsule, soft gelatin capsule (SGC), hard gelatin capsule (HGC), and non-gelatin capsule. The demand for non-animal-based products and the various advantages of non-gelatine capsules over gelatine capsules, such as physical stability, integrity in different ranges of temperature and humidity, and low moisture content, are driving the growth of the non-gelatine capsules segment. This segment is projected to register the highest CAGR during the forecast period.

By Functionality:

• immediate-release capsules
• sustained-release capsules
• delayed-release capsules

By functionality, the global market is bifurcated as immediate-release capsules, sustained-release capsules, and delayed-release capsules. The immediate-release capsule segment is growing rapidly in the market, as it is widely used for the production of antibiotics, antibacterials, antacids, painkillers, inhalers, cough and cold treatments, and dietary supplements. It is also a common form of medication prescribed to treat a variety of illnesses.

By Therapeutic Application:

• Vitamin and Dietary Supplements
• Antibiotic and Antibacterial Drug
• Antacids and Anti-flatulent Preparation
• Cardiac Therapy Drug
• Other

On the basis of therapeutic application, the global empty capsules market is segmented as vitamin and dietary supplements, antibiotic and antibacterial drug, antacids and anti-flatulent preparation, cardiac therapy drug, and other. The dietary supplement segment has seen a rapid rate of growth in the market, driven by factors such as heightened health consciousness and pricing for emerging countries, the rising prevalence of lifestyle diseases, and the heightened use of Vitamin capsules as they are available over-the-counter. These have all contributed to the growth of this segment.

By End-User:

• Pharmaceutical Companies
• Cosmetics Companies
• Nutraceutical Companies
• Others

Based on end-user, the global market is segmented as pharmaceutical companies, cosmetics companies, nutraceutical companies, and others. The end-user segment of the market is expected to experience similar levels of growth, though the research laboratory and pharmaceutical industries are projected to dominate the market.

By Region:

• North America

  • U.S.
  • Canada

• Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

• Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

• Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

• Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA

North America is expected to dominate the global empty capsules market owing to the increasing prevalence of cardiovascular diseases due to change in lifestyle in this region. According to the American Heart Association Research Report 2018, cardiovascular diseases, recorded as the fundamental reason for death, represents almost 836,546 deaths in the United States. This is almost one out of each three deaths in the country. Besides, adoption of latest technologies and development of innovative products elevates the market growth in this region. For instance; In July 2018, Lonza's Capsule Delivery Solutions dispatched the CapsugelVcaps Gen C capsule dependent on the carrageenan gelling-agent plan, growing Lonza's Capsugel Hydroxypropyl Methyl Cellulose (HPMC) portfolio.

Asia Pacific is the fastest developing area in empty capsule market owing to the growing population and increasing awareness in this region. Growing application in pharmaceutical and nutraceutical companies are also supplementing the market growth. For example, Lonza is a global integrated solutions provider for pharma, consumer healthcare and nutrition segments. Lonza India is a subsidiary of Switzerland-based. Lonza dispatched Capsugel Zephyr, its new dry-powder inward breath container portfolio for customized answers for ideal pulmonary drug delivery in 2019. According to a news published on January 16th, 2020, Lonza India had set the target of doubling its turnover with an estimated growth of over 14 per cent by 2024. Also, increasing need for better diagnostic devices, rapidly improving technology, better and safe therapeutic approach may drive the market growth in this region.

Market Drivers-

Advancements in capsule delivery technologies

The major factor driving the growth of global of empty capsules market is advancement in capsule delivery technology. Technological innovations have provided the empty capsule industry with a developing scope of usefulness choices for capsule-based formulations utilized by patients. In recent years, capsule delivery has seen various technological adaptions in terms of item advancement for better quality results and patient comfort.

These incorporate the improvement of capsule shells, capsule-sealing technique, fill material, and capsule systems to accomplish changed drug release and the encapsulation of various materials. Another key innovation is the development of capsule-in-capsule innovation to ensure gastric-delicate active ingredients. This takes into account the utilization of insignificant recipients for plan, improvement of upper gastrointestinal safety, separated pharmacokinetic execution, and improved item advancement.

Increasing prevalence of dietary supplements

In addition, increasing prevalence of dietary supplements is also fostering the market growth. The increasing prevalence of dietary supplements to boost the immunity attributes the growth of empty capsules market. In U.S., 170 million people taking dietary supplements such as vitamin C, vitamin D, multivitamins, and vitamins B/B complex are efficient supplements.

Furthermore, rising prevalence of the geriatric population and the associated chronic conditions are also supplementing the growth of global empty capsule market. The developing geriatric population globally builds the interest for different treatment drugs and dietary enhancements, for better health results. As per the United Nations, World Population Prospects: by 2050, one out of six individuals on the planet will be over age 65, up from one of every 11 out of 2019.

Recent Developments-

• March 10, 2021; CapsCanada announced the launch of a new liquid-filled hard capsule manufacturing service. CapsCanada has idealized the technology for creating and assembling fluid filled hard capsules (LFHCs). With this innovation, fluids, glues, suspensions, semi-solids and waxy substances would all be able to be filled into gelatin or HPMC vegan two-piece capsules. CapsCanada's goal is to help the whole manufacturing measure, from formulation and advancement through full-scale production. In making this service CapsCanada cooperated with one of the main manufacturers of conventional and branded drugs in Canada. Creation will be done at a committed Health Canada-approved office in Canada that has a full insightful lab, permitting for controlled drugs and substances including narcotics.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2020:	USD 2256.9 Million
Base year considered	2020
Forecast Period CAGR %:	7.35 %
Market Size Expected in 2027:	USD 3707.8 Million
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	ACG Worldwide, CapsCanada Corporation, Bright Pharma Caps Inc., Sunil Healthcare Ltd., Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd, Qingdao Yiqing Medicinal Capsules Co. Ltd., Lonza Group AG,  HealthCaps India Ltd., others.
Segments Covered	By Product, By Functionality, By Therapeutic Application, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa